Retinoblastoma

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
5 Unique IMPs
0 Commercial trials
Drug classes (ATC)
L Oncology (ATC L) 1
Mechanism of action (INN-stem analysis)
Platinum compound 1 substance
Alkylating agent 1 substance
Topoisomerase II inhibitor 1 substance
Unknown / small molecule 1 substance
Vinca alkaloid 1 substance
Phase II: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase II

1 trial
  • Institut Curie Academic
    CARBOPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; THIOTEPA; VINCRISTINE SULFATE
    2024-514844-10-00 1 country 2010 n=195
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Institut Curie Academic 1 Phase II 0
← All indication landscapes